Advancing biologics manufacturing
Optimize biologics manufacturing with Recombinant Insulin—enhancing cell growth, yield, and process consistency for therapeutic production.
Boost cell-based vaccine production with Recombinant Insulin
Boost cell-based vaccine production with Recombinant Insulin. It not only increases viable cell density but also boosts virus and VLP production significantly.
Recombinant Insulin HEK293 poster
Monoclonal antibodies | Viral vectors for gene therapy | Cell-based vaccinees | Pluripotent stem cells
Recombinant Insulin HEK293 poster
Monoclonal antibodies | Viral vectors for gene therapy | Cell-based vaccinees | Pluripotent stem cells
Recombinant Insulin Sf9 poster
Monoclonal antibodies | Viral vectors for gene therapy | Cell-based vaccinees | Pluripotent stem cells
Enhancing process efficiency with high-quality animal-free ingredients
Recombinant Insulin is the essential cell culture ingredient to boost cell proliferation and productivity
Effect of Insulin on influenza virus production in HEK293 Cells
Mammalian cells are considered an alternative to eggs for the production of influenza vaccines. HEK293SF-3F6 is a suspension GMP cell line that grows in serum-free media, and influenza production has been achieved in flasks and large bioreactors. To boost influenza production, insulin was added to the cultures. This growth factor was chosen because it has […]
The Insulin peptide family
Monoclonal antibodies | Viral vectors for gene therapy | Cell-based vaccinees | Pluripotent stem cells
The insulin and IGF-1 receptors
Monoclonal antibodies | Viral vectors for gene therapy | Cell-based vaccinees | Pluripotent stem cells
